Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers
Clinical trial NCT06531512 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06531512
- Sponsor
- Oneness Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-16
- Primary completion
- 2026-05-08
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.